Compare LAKE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAKE | PYPD |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.6M | 76.4M |
| IPO Year | 1986 | 2020 |
| Metric | LAKE | PYPD |
|---|---|---|
| Price | $9.36 | $4.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $17.33 | $12.00 |
| AVG Volume (30 Days) | ★ 143.8K | 78.0K |
| Earning Date | 12-09-2025 | 02-11-2026 |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,456,000.00 | N/A |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $8.32 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 27.42 | N/A |
| 52 Week Low | $7.77 | $2.30 |
| 52 Week High | $25.53 | $5.12 |
| Indicator | LAKE | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 47.81 | 45.68 |
| Support Level | $9.27 | $4.52 |
| Resistance Level | $9.84 | $5.12 |
| Average True Range (ATR) | 0.34 | 0.32 |
| MACD | 0.13 | -0.05 |
| Stochastic Oscillator | 57.79 | 11.49 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.